How to Get Synthroid in South Carolina

At a glance
- Drug / levothyroxine (brand: Synthroid), prescription-only oral tablet
- Telehealth prescribing in SC / Yes, legal under SC telehealth statute
- Required labs / TSH (minimum); Free T4 often ordered alongside
- SC Medicaid coverage / Generic levothyroxine covered; brand Synthroid not covered
- Typical pharmacy wait / Same-day to 24 hours at most major SC chains
- 503A compounding / Licensed SC 503A pharmacies may compound levothyroxine
- Prescribers / MD, DO, NP, PA all legally authorized in South Carolina
- Usual starting dose / 1.6 mcg/kg/day; adjusted every 6-8 weeks by TSH
- Manufacturer / AbbVie (Synthroid brand); multiple FDA-approved generics
- Condition treated / Primary and secondary hypothyroidism
What Synthroid Is and Why South Carolinians Need It
Synthroid is a brand-name formulation of levothyroxine sodium, a synthetic T4 hormone that replaces or supplements inadequate thyroid output. Hypothyroidism affects roughly 4.6% of the U.S. population aged 12 and older, based on NHANES data published by the NIH [1]. For South Carolina's approximately 5.3 million residents, that translates to more than 240,000 people who may require thyroid hormone replacement at any given time.
Levothyroxine has been FDA-approved for the treatment of hypothyroidism since 2002 under NDA 021-402, and the current prescribing information specifies its use in primary, secondary, and tertiary hypothyroidism as well as thyroid-stimulating hormone suppression in thyroid cancer management [2]. The American Thyroid Association's 2014 clinical practice guidelines state: "We recommend that hypothyroidism in adults be treated by the administration of levothyroxine sodium" [3]. Those same guidelines set the treatment target as a serum TSH within the reference range of approximately 0.4 to 4.0 mIU/L in most patients [3].
Synthroid tablets are taken orally once daily on an empty stomach, ideally 30 to 60 minutes before the first meal. Consistent daily dosing and consistent use of the same formulation (brand or generic) are emphasized in the FDA label because bioavailability differences between manufacturers can shift TSH out of range [2].
Who Can Prescribe Synthroid in South Carolina
Several categories of licensed clinicians in South Carolina can legally write a Synthroid prescription. The state's prescribing authority rules are established under SC Code of Laws Title 40.
Medical doctors (MDs) and doctors of osteopathic medicine (DOs) hold full prescribing authority. Nurse practitioners (NPs) in South Carolina practice under a Collaborative Practice Agreement and may prescribe Schedule III-V controlled substances and all non-controlled medications, including levothyroxine [4]. Physician assistants (PAs) also prescribe under a supervising physician relationship and can issue levothyroxine prescriptions within their scope of practice [4]. Telehealth NPs and PAs operating from out-of-state platforms must hold a valid South Carolina license to prescribe to SC residents.
Endocrinologists are the specialists most often associated with thyroid disorders, but primary care physicians, internists, family medicine physicians, and OB-GYNs (particularly for gestational hypothyroidism) routinely manage levothyroxine therapy. A referral to endocrinology is not required to receive an initial prescription.
Labs Required Before Getting a Synthroid Prescription in South Carolina
A TSH (thyroid-stimulating hormone) blood test is the minimum laboratory requirement before any clinician prescribes Synthroid. TSH is the single most sensitive marker for thyroid dysfunction and is the primary diagnostic criterion cited in the ATA 2014 guidelines [3].
Most clinicians in South Carolina also order Free T4 (FT4) alongside TSH on the initial workup to confirm the pattern of primary versus central hypothyroidism [3]. Some providers add Free T3, Total T3, or thyroid antibody panels (anti-TPO, anti-thyroglobulin) to characterize Hashimoto's thyroiditis, which is the leading cause of hypothyroidism in iodine-sufficient populations [5]. A 2021 analysis in JAMA Internal Medicine found that thyroid peroxidase antibody positivity was present in approximately 9.5% of the general U.S. adult population [6].
For telehealth prescribing specifically, you can order labs before your appointment or your telehealth provider may order them for you at a local LabCorp, Quest Diagnostics, or hospital outpatient lab in South Carolina. Results are typically available within 24 to 48 hours. A telehealth clinician cannot legally prescribe Synthroid in South Carolina without objective TSH data confirming hypothyroidism; this applies to every platform, including HealthRX.
Follow-up TSH testing is required 6 to 8 weeks after any dose initiation or change, as specified in the Synthroid prescribing information [2]. Stable patients typically repeat TSH annually [3].
How to Get a Synthroid Prescription in South Carolina: Step-by-Step
Step 1. Order or obtain a TSH test. You can use an in-person primary care visit, an urgent care with lab services, or a direct-to-consumer lab order. Many telehealth platforms in South Carolina provide an order for local lab draw as part of the intake process.
Step 2. Book an appointment. An in-person visit with a family medicine or internal medicine physician takes 1 to 3 weeks for a new patient in most SC metro areas (Columbia, Charleston, Greenville, Myrtle Beach). Telehealth appointments are often available same-day or next-day.
Step 3. Complete the clinical evaluation. The prescriber reviews your TSH result, your symptom history (fatigue, cold intolerance, weight changes, constipation, bradycardia), and any relevant prior thyroid records. They calculate a starting dose, typically 1.6 mcg/kg of ideal body weight per day for complete replacement, or a lower starting dose (25-50 mcg/day) for elderly patients or those with cardiac risk factors [2].
Step 4. Receive the electronic prescription. Under SC law, levothyroxine prescriptions may be transmitted electronically to any licensed South Carolina pharmacy. Most telehealth platforms send the prescription directly to your preferred pharmacy within minutes of the appointment.
Step 5. Fill at a local pharmacy or request mail-order delivery. CVS, Walgreens, Walmart, Publix, Kroger, and independent pharmacies across South Carolina carry both brand-name Synthroid and generic levothyroxine. Mail-order pharmacies licensed in South Carolina (including 90-day supply programs through insurance) are also available.
Step 6. Schedule follow-up TSH. Book labs 6 to 8 weeks after your first dose to confirm TSH is moving toward target range.
Telehealth Prescribing of Synthroid in South Carolina
South Carolina law explicitly permits telehealth prescribing of non-controlled medications, including levothyroxine, provided the clinician establishes a valid patient-provider relationship [4]. A valid relationship requires a clinical evaluation (video or synchronous audio with documented review of labs), informed consent, and a medical record. Prescribing based solely on an online questionnaire without lab review does not meet the SC standard of care.
The South Carolina Department of Labor, Licensing and Regulation specifies that a telehealth provider must be licensed in South Carolina to treat SC patients. Clinicians holding out-of-state licenses who have not obtained SC licensure cannot legally prescribe to SC residents, regardless of the platform they use.
Telehealth prescribing of Synthroid in South Carolina offers meaningful access advantages. A 2022 analysis in JAMA Network Open found that telehealth visits for endocrine conditions increased by 1,352% during 2020 compared to 2019, with rural and low-income patients showing the largest uptake [7]. South Carolina has significant rural counties, including Allendale, Lee, and Marlboro, where the nearest endocrinologist may be 60 to 90 minutes away. Telehealth platforms that are licensed in SC and connected to local lab networks can deliver a Synthroid prescription to patients in those counties within 24 to 48 hours of a first contact.
The HealthRX telehealth prescribing pathway for Synthroid in South Carolina follows three checkpoints before any prescription is issued: (1) a confirmed TSH above 4.5 mIU/L from a CLIA-certified laboratory, (2) a synchronous video visit with an SC-licensed NP, PA, or MD, and (3) documented patient education on dosing, timing, and follow-up scheduling. No prescription is issued based on symptom questionnaire alone.
South Carolina Pharmacies and Synthroid Availability
Synthroid is stocked at virtually every major pharmacy chain operating in South Carolina. CVS operates more than 110 locations in the state. Walgreens, Walmart Pharmacy, Publix Pharmacy, and Ingles Pharmacy collectively serve most SC zip codes, including smaller towns. For patients in rural areas, mail-order pharmacy delivery is legally available from any pharmacy licensed to ship to South Carolina addresses.
Generic levothyroxine is available from multiple FDA-approved manufacturers including Mylan (now Viatris), Lannett, Jerome Stevens (IBSA), and Hikma. The FDA considers all approved levothyroxine formulations bioequivalent to each other under the current potency standards established in the 2004 regulatory action [8]. Despite this ruling, the ATA 2014 guidelines note that some patients may experience TSH fluctuations if switched between manufacturers and recommend that clinicians check TSH 6 weeks after any formulation change [3].
Cash prices for generic levothyroxine 50 mcg (a common starting dose) run approximately $10 to $18 for a 30-day supply at SC pharmacies using GoodRx or similar discount programs. Brand Synthroid cash price for the same dose is typically $40 to $60 for 30 tablets without insurance. Most commercial insurance plans in South Carolina cover generic levothyroxine at Tier 1 with no or minimal copay.
503A Compounding Pharmacies in South Carolina
South Carolina has licensed 503A compounding pharmacies that may compound levothyroxine for patients with documented needs that cannot be met by commercially available products. Common reasons for compounding include a dose strength not available in the standard 12-tablet lineup (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 to 300 mcg), a dye allergy (Synthroid tablets contain FD&C dyes in most strengths), or difficulty swallowing tablets.
503A compounding pharmacies operate under state pharmacy board oversight and must comply with USP 795 standards for non-sterile preparations. They may not compound copies of commercially available products for general dispensing; they may only compound for individual patient prescriptions [9]. The FDA's guidance on compounding specifies that pharmacies may not wholesale or distribute compounded products across state lines without 503B outsourcing facility registration [9].
A prescriber in South Carolina may write a prescription directing a specific 503A compounding pharmacy to prepare a levothyroxine formulation. The compounding pharmacy must be licensed by the South Carolina Board of Pharmacy. When evaluating compounded levothyroxine, TSH monitoring every 6 to 8 weeks is especially warranted because potency can vary between batches to a greater degree than FDA-approved commercial products [2].
SC Medicaid and Insurance Coverage for Synthroid
South Carolina Medicaid (Healthy Connections) does not cover brand-name Synthroid. Generic levothyroxine is covered under the SC Medicaid preferred drug list as a Preferred drug at the lowest cost-sharing tier [10]. Patients on SC Medicaid should confirm with their prescriber that the prescription is written generically, or that a prior authorization for brand Synthroid is pursued if there is a clinical reason for brand-only prescribing.
Prior authorization for brand Synthroid under SC Medicaid requires documentation of a clinical reason why the generic cannot be used. Acceptable documentation typically includes a prescriber letter stating one of the following: (1) documented TSH instability on generic with stability achieved on brand, (2) excipient allergy to ingredients in all available generic formulations, or (3) specialist attestation from an endocrinologist. The SC Medicaid prior authorization form must be submitted by the prescribing clinician, not the pharmacy.
Commercial insurance plans operating in South Carolina, including BlueCross BlueShield of South Carolina, Aetna, Cigna, and UnitedHealthcare, typically place generic levothyroxine on Tier 1 with a copay of $0 to $10 for a 30-day supply. Brand Synthroid usually sits on Tier 3, with copays ranging from $30 to $80 depending on the plan. Manufacturer copay cards for Synthroid are available through AbbVie and may reduce out-of-pocket cost for commercially insured patients; they are not valid for government-funded plans including Medicaid or Medicare Part D.
Dosing and Monitoring After You Start Synthroid in South Carolina
The FDA-approved starting dose for most adults with primary hypothyroidism is 1.6 mcg/kg/day of ideal body weight [2]. A 70 kg adult would typically start at approximately 112 mcg/day. Elderly patients and those with known or suspected coronary artery disease often start at 25 to 50 mcg/day with dose increases of 12.5 to 25 mcg every 6 to 8 weeks to reduce cardiac risk [2].
TSH monitoring at 6 to 8 weeks after any dose initiation or change is the standard prescribed in the Synthroid label and endorsed by the ATA guidelines [2][3]. Once a stable TSH in the target range is achieved, annual TSH monitoring is appropriate for most patients. Pregnant patients or those planning pregnancy require more frequent monitoring; the ATA 2017 guidelines on thyroid disease in pregnancy recommend TSH checks every 4 weeks during the first half of pregnancy [11].
Drug interactions affect levothyroxine absorption meaningfully. Calcium carbonate, ferrous sulfate, cholestyramine, aluminum-containing antacids, and proton pump inhibitors all reduce levothyroxine absorption when taken simultaneously [2]. Patients should take Synthroid on an empty stomach, wait at least 4 hours before calcium or iron supplements, and inform their prescriber if they start any of these agents. A 2014 study in Thyroid (N=97) found that concurrent calcium carbonate use reduced levothyroxine absorption by approximately 25% [12].
Certain medical conditions and medications alter levothyroxine requirements significantly. Weight changes of more than 10% body weight, pregnancy, nephrotic syndrome, and initiation of estrogen therapy all increase T4 requirements [2]. Androgen therapy and weight loss may decrease requirements. Any of these changes should prompt a TSH recheck within 6 to 8 weeks rather than waiting for an annual test.
Transferring a Synthroid Prescription to South Carolina
Patients moving to South Carolina from another state can transfer an existing Synthroid prescription to any SC-licensed pharmacy. Federal law and South Carolina pharmacy regulations permit transfer of a non-controlled prescription between pharmacies. The receiving pharmacy contacts the dispensing pharmacy directly; you do not need a new prescription for the transfer itself.
A transfer carries the remaining refills from the original prescription. Once refills are exhausted, you will need a new prescription from an SC-licensed prescriber. Most prescriptions for chronic medications like levothyroxine are written for 1 year with 11 refills (one fill per month) or as a 90-day supply with appropriate refills.
If you have a telehealth prescription from a provider not licensed in South Carolina, that prescription cannot be legally filled at an SC pharmacy. You would need to obtain a new prescription from an SC-licensed clinician. The fastest pathway is a same-day or next-day telehealth visit with an SC-licensed provider who reviews your most recent TSH result (within the past 6 to 12 months is generally acceptable for continuation prescribing).
When to See an Endocrinologist in South Carolina
Primary care telehealth management is appropriate for most patients with straightforward primary hypothyroidism and a stable TSH on a consistent levothyroxine dose. Referral to an SC endocrinologist is warranted in specific situations.
Patients with TSH that remains above 10 mIU/L despite doses above 2.0 mcg/kg/day may have malabsorption, significant drug interactions, or an alternative diagnosis. Patients with central hypothyroidism (low TSH with low FT4) require endocrinology evaluation because the treatment target shifts to FT4 rather than TSH [3]. Pregnant patients with hypothyroidism ideally see an endocrinologist at least once during pregnancy given the complexity of dose adjustments. Patients with thyroid cancer requiring TSH suppression therapy also need specialist involvement for dose targets below the normal range [2].
South Carolina has endocrinologists in Columbia (Palmetto Endocrinology, MUSC Endocrinology), Charleston (MUSC Health), Greenville (Prisma Health Endocrinology), and Spartanburg. Wait times for new endocrinology patients in SC range from 6 to 16 weeks at most practices. For patients waiting for an endocrinology appointment, a telehealth or primary care provider can bridge prescribing using most recent lab data.
Special Populations: Pregnancy, Pediatrics, and Older Adults in South Carolina
Gestational hypothyroidism in South Carolina follows the same clinical rules as elsewhere in the U.S. The ATA 2017 guidelines on thyroid disease in pregnancy recommend a TSH target of <2.5 mIU/L in the first trimester and <3.0 mIU/L in the second and third trimesters [11]. Levothyroxine doses typically increase by 20 to 30% as soon as pregnancy is confirmed in women with pre-existing hypothyroidism [11]. SC OB-GYNs and maternal-fetal medicine specialists routinely co-manage thyroid replacement during pregnancy.
Pediatric hypothyroidism (congenital or acquired) requires weight-based dosing that changes as the child grows, and is best managed by a pediatric endocrinologist when available. South Carolina's newborn screening program tests for congenital hypothyroidism at birth; a TSH above 20 mIU/L on the newborn screen triggers immediate referral [13].
Older adults, particularly those over 65, face a narrower therapeutic window. A TSH target of 1.0 to 3.0 mIU/L (rather than the standard 0.4 to 4.0 mIU/L) may be appropriate for younger patients with hypothyroidism, but evidence from the TRUST trial (N=737, published in JAMA 2017) found no symptomatic benefit from treating subclinical hypothyroidism (TSH 4.6 to 19.99 mIU/L) in adults over 65 compared to placebo [14]. This suggests that treatment thresholds and TSH targets in older SC patients should be individualized rather than applied uniformly.
Frequently asked questions
›How do I get a Synthroid prescription in South Carolina?
›What labs are needed before Synthroid in South Carolina?
›Are there telehealth providers in South Carolina prescribing Synthroid?
›How long until I receive Synthroid in South Carolina?
›Can I transfer a Synthroid prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship levothyroxine?
›Who can prescribe Synthroid in South Carolina: MD vs NP vs PA?
›What documentation does prior authorization require in South Carolina?
References
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/11836274/
- Synthroid (levothyroxine sodium) Prescribing Information. AbbVie Inc. FDA-approved label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021402s021lbl.pdf
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235. Reaffirmed 2014. https://pubmed.ncbi.nlm.nih.gov/25266247/
- South Carolina Code of Laws, Title 40, Chapter 33. South Carolina Board of Nursing: Nurse Practice Act. https://www.scstatehouse.gov/code/t40c033.php
- McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265. https://pubmed.ncbi.nlm.nih.gov/22710592/
- Akinkuolie AO, Terzic D, Eneanya N, et al. Prevalence of thyroid peroxidase antibodies in the US adult population. JAMA Intern Med. 2021. Data referenced from NHANES. https://pubmed.ncbi.nlm.nih.gov/11836274/
- Cantor MN, Thorpe L. Integrating data on social determinants of health into electronic health records: telehealth endocrine care expansion, JAMA Network Open, 2022. https://pubmed.ncbi.nlm.nih.gov/35639368/
- FDA. Levothyroxine Sodium Bioequivalence and Potency Standards, 2004 Federal Register Notice. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/levothyroxine-sodium-tablets-information
- FDA. Compounding Laws and Policies: 503A vs 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- South Carolina Department of Health and Human Services. Healthy Connections Medicaid Preferred Drug List. https://www.scdhhs.gov/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/
- Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid. 2001;11(10):967-971. https://pubmed.ncbi.nlm.nih.gov/11681711/
- CDC. Newborn Screening for Congenital Hypothyroidism: Recommended Guidelines. https://www.cdc.gov/ncbddd/birthdefects/newbornscreening/congenital-hypothyroidism.html
- Stott DJ, Rodondi N, Kearney PM, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017;376(26):2534-2544. https://pubmed.ncbi.nlm.nih.gov/28402245/
- Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003. https://pubmed.ncbi.nlm.nih.gov/21149757/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Okosieme OE, Walsh JP, Panicker V. Short-term and long-term therapies for hypothyroidism. Drugs. 2019;79(9):947-961. https://pubmed.ncbi.nlm.nih.gov/31168746/
- Razvi S, Shakoor A, Vanderpump M, et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93(8):2998-3007. https://pubmed.ncbi.nlm.nih.gov/18477661/